Formative—Aradigm Annual Report for 2002:

Contact Us	Free Donuts	Search the Site	Sitemap	Workroom







Investor Relations Sunesis Threshold United Commercial Bank (UCBH) Netflix Fair, Isaac Chiron Onyx Barra Solectron PeopleSoft ALZA Caliper Technologies Aradigm ProBusiness Protein Design Labs Union Bank Foundation Sangamo BioSciences The Asia Foundation The California Endowment BioTime			Formative—Aradigm Annual Report for 2002: Aradigm, a leader in pulmonary drug delivery, has made landmark progress by advancing its lead therapy into the final phase of clinical trials. The 2002 annual signals to investors that Aradigm's aerosol-based alternative to painful injected therapies will soon be reaching patients. The editorial section of the book is bound directly to the 10K presenting a clean, cohesive, and cost effective investment package. Aradigm 2002 Annual Report - Online About Aradigm